-
Interviews with leading Life Sciences companies: Pixie Dust Technologies
Pixie Dust Technologies invented a new audio method with gamma wave sound to prevent or … Read more
-
Life Sciences M&A Report: Half-Year 2023
In the first half of 2023, the slowdown in terms of global life sciences M&A … Read more
-
ライフサイエンス 企業: 欧州事業拠点の 立地選定
ライフ サイエンス事業を立ち上げたり拡大したりする際に、適切な場所を選択するのは簡単なことではありません。 Venture Valuation との協力により KPMG が作成したこのレポートでは、欧州における事業拠点選定プロセスの概要と、各国の包括的分析内容を提供いたします。
-
Site Selection for Life Sciences Companies in Europe
Choosing the right location when setting up or expanding your life science operations is no … Read more
-
A Formula for Drug Licensing Deals
Venture Valuation’s Elias Neuendorf, Kara E. O’Connell, Patrik Frei and Kumlesh Kumar Dev recently had … Read more
-
Heartseed Inc., Breakthrough cell therapy for severe heart failure.
As an innovative new treatment option for heart failure, a unique cardiac remuscularization therapy has … Read more
-
How to assess start-up companies
Relevant soft factors to assess startup companies Investing in early-stage companies is a risky business. … Read more
-
Site Selection for Life Sciences Companies in Asia – New Report in Collaboration with KPMG
Zurich / Singapore, July 2020 – In response to the growing need of life sciences … Read more
-
Do Biotech Investors stick to their Home Market?
It is no surprise that most biotech investors are based in the US. But, do … Read more
-
J.P. Morgan Healthcare Conference Round-up by Venture Valuation / Biotechgate
14 January 2019. Last week saw the annual J.P. Morgan Healthcare Conference held in San … Read more